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Abstract
Introduction: Roux- en- Y choledochojejunostomy and duct- to- duct (D- D) anastomosis 
are biliary reconstruction methods for liver transplantation. However, there is a contro-
versy over which method produces better results. We have compared the outcome of 
D- D anastomosis vs. Roux- en- Y hepaticojejunostomy in patients with primary  sclerosing 
cholangitis who had undergone liver transplant in Shiraz Organ Transplant Center.
Materials: The medical records of 405 patients with primary sclerosing cholangitis 
(PSC) who had undergone liver transplant from 1996 to 2015 were reviewed. Patients 
were divided into two groups: Roux- en- Y group and D- D group. Morbidity, disease 
recurrence, and graft and patient survival rates were compared between the two 
groups.
Results: Total of 143 patients underwent a D- D biliary reconstruction, and 260  patients 
had a Roux- en- Y loop. Biliary complication involved 4.2% of patients from the D- D 
group, and 3.9% from the Roux- en- Y group (P=. 863). Actuarial 1- , 3- , and 5- year patient 
survival for D- D and Roux- en- Y group was 92%, 85%, and 74%; and 87%, 83%, and 
79%, respectively (P=.384). The corresponding 1- , 3- , and 5- year probability of biliary 
complication was 97%, 95%, and 92%; and 98%, 97%, and 94%, respectively (P=.61).
Conclusion: Duct- to- duct biliary reconstruction in liver transplantation for selected 
patients with PSC is a good alternative instead of Roux- en- Y biliary reconstruction.
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1  | INTRODUCTION
Primary sclerosing cholangitis (PSC) is a chronic liver disease of un-
known causes, which progresses toward fibrosis and biliary obstruc-
tion. Eventually, the disease leads to liver failure, cholangitis, or even 
cholangiocarcinoma (CCA).1
To this day, no certain treatment has been identified; the only 
effective treatment for patient with PSC in the final stage is liver 
transplantation.2 Although liver transplant is an acceptable treat-
ment for patient with PSC in the final stage, biliary complications are 
more common in this group compared to other groups receiving liver 
transplants.3
Even though the standard method is controversial, a variety of bili-
ary reconstruction methods have been used in liver transplantation for 
primary sclerosing cholangitis. It was previously reported that a Roux- 
en- Y loop reconstruction reduces postoperative strictures and has 
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better patient and graft survival rate comparing to duct- to- duct (D- D) 
reconstruction. However, sometimes it is preferable to use D- D anas-
tomosis because of easier accessibility to bile ducts; this method also 
keeps the anatomy of the biliary system and the sphincter function 
natural and therefore prevents infection and septicemia. Compared 
to Roux- en- Y, D- D reconstruction has shorter surgical duration and a 
more convenient postoperative recovery period.4
In a systematic review, one study compared the two methods 
for anastomosis of the bile ducts (Roux- en- Y vs D- D) in patients with 
PSC. However, they found no significant differences between the two 
groups regarding 1- year patient and graft survival rates, risk of biliary 
complications, and disease recurrence.5
One meta- analysis, which analyzed 10 articles relating Roux- 
en- Y vs D- D methods for reconstruction of biliary ducts in patients 
with PSC, found no differences between the two techniques regard-
ing occurrence of biliary stricture and biliary anastomotic leakage. 
Furthermore, there were no differences in postoperative mortality 
rates. Even though Roux- en- Y has a higher rate of cholangitis, the 
 1- year graft survival, disease recurrence, and spread of cholangiocar-
cinoma are comparable between the two groups.6
In general, D- D is the preferable method for anastomosis of bile 
ducts following liver transplantation, but some centers use the Roux- 
en- Y method in PSC cases. Although some centers have presented 
satisfactory short- term results from D- D anastomosis of selected pa-
tients with PSC, the long- term results of these techniques have not yet 
been properly explained.
This study aims to compare patient and graft survival rates and 
biliary complications between the two methods of DD and RY recon-
struction of bile ducts in the patients with PSC who visited Nemazee 
Hospital in Shiraz for liver transplantation during the course of the past 
19 years.
2  | MATERIALS AND METHODS
In this retrospective cohort study, we reviewed the medical 
 records of patients with PSC who underwent liver transplantation 
in Nemazee Hospital in Shiraz, during the years 1996- 2015. The 
 diagnosis of PSC was based on pre- operative magnetic resonance 
cholangiopancreatography (MRCP) and liver  biopsy. A total 405 pa-
tients with primary sclerosing cholangitis were  enrolled for the final 
analysis. We made a comparison of  patient and graft survival rates 
and occurrence of biliary complications among them regarding the 
two methods of biliary duct reconstruction: Roux- en- Y and D- D.
Data collection form consisted of demographic information (age, 
gender), biliary complications, biliary reconstruction technique, and 
type of liver transplant, surgical variables and the demographic infor-
mation of liver donors. Any biliary complications that required hos-
pitalization and involved surgery and endoscopy were considered 
as postoperative biliary complication. Biliary complications such as 
leakage, stricture, and residual stones; malignancy in bile duct; and 
graft loss; and patient survival rates were compared between the two 
groups.
In our center, decision on the type of biliary reconstruction (D- D 
anastomosis or Roux- en- Y hepaticojejunostomy) is based on the as-
sessments made by the surgeon. Assessment was based on finding 
during operation such as normal mucosa and open common bile ducts, 
without inflammation and wall thickness, and progressive passing 
the probe into the duodenum. If the surgeon does not find any evi-
dence of impaired bile flow, irregularity of bile duct, malignancy, or 
pre- malignancy, D- D anastomosis should be the first choice. At least 
two surgeons make decision for type of biliary construction. This is 
according to Shiraz transplant center protocol. We take frozen sec-
tion in cases of malignancy to confirm, R0 resection, and also common 
bile duct completely removed until its entrance to pancreas during 
 Roux- en- Y hepaticojejunostomy, and send for pathology.
2.1 | Statistical analysis
For data analysis, in addition to descriptive statistics, we used the 
t test to compare mean of continuous variables and the chi- square to 
compare the categorical variables between the two groups with the 
alpha level of lower than 5%; patient and graft survival rates were cal-
culated and compared through the log- rank test and the Kaplan- Meier 
estimator. SPSS- 18 was the software used.
3  | RESULTS
Of the 405 patients who received liver transplants for PSC, 
257 (63.5%) were males; average age of the recipients was 
35.1±11.4 years. There was a donor/recipient sex mismatch in 
44.4% of the cases. In 93.4% of all the cases, a whole organ graft 
was used. Follow- up duration varied from 6 months to 19 years. 
Two hundred and sixty patients received a Roux- en- Y hepaticoje-
junostomy anastomosis during liver transplantation, and D- D biliary 
anastomosis was used for 143 patients.
There was a significant difference between the groups regard-
ing age and gender of donors and recipients, which was clinically 
insignificant. No significant differences were observed between 
surgical variables based on the methods of biliary reconstruction 
(Table 1).
Mean and median survival rates were 132±4.9 and 172.5 months, 
respectively. One- year patient survival was 89%, 3- year survival 84%, 
and 5- year survival 77%, for all patients. One- year graft survival was 
97%, 3- year 92%, and 5- year 91% for all patients. Survival probabili-
ties and events of death were compared between the two groups of 
D- D and R- Y via the log- rank test.
The D- D group had a 1- year survival of 92%, a 3- year survival of 
85%, and a 5- year survival of 74%, while in the Roux- en- Y group,  1- year 
survival was 87%, 3- year survival 83%, and 5- year survival 79%, a  result 
which revealed no significant differences between the two groups 
(P value=.384) (Figure 1). Seventy deaths occurred after liver transplan-
tation (17.3%); the causes of death are summarized in Table 2. The most 
common cause was sepsis (4%), and chronic rejection was second at 
3%. Cholangiocarcinoma was reported in 17 (4.2%) cases.
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3.1 | Biliary complications
Postoperative biliary complications were reported in 16 (4%) cases; 
the Roux- en- Y group had 10 (3.9%) cases of biliary stricture, and six 
(4.2%) cases of stricture were reported in the D- D group. No signifi-
cant differences were observed (P value=.863). In the R- Y group, PTC, 
balloon dilation, and stenting were performed for every patient and 
two cases received common bile duct exploration following PTC. For 
the complications in the D- D group, ERCP was performed in three 
cases, Roux- en- Y procedure in two cases and revision of anastomosis 
in one case. Only one case of cholangitis was reported among the 
patients in the Roux- en- Y group.
F IGURE  1 Survival for patients 
who had duct- to- duct (D- D) biliary 
reconstruction vs patients who had a  
Roux- en- Y anastomosis
Duct- to- Duct  
Group 143 (35.5%)
Roux- en- Y  
Group 260 (64.5%) P Value
Donor variables
Age (y)* 32.3±13.3 29.4±11.3 .027
Sex (%)
Male 91 (65.9) 186 (72.7) .164
Female 47 (34.1) 70 (27.3)
Sex mismatch/match
sex mismatch donor- recipient [n (%)] 68 (49.3) 107 (41.8) .154
sex match donor- recipient [n (%)] 70 (50.7) 149 (58.2)
Recipient variables
Age (y)* 37.1±12.4 34.1±10.6 .017
Sex [n (%)]
Male 80 (56) 176 (67.7) .019
Female 63 (44.1) 84 (32.3)
Surgical variables
Warm ischemia time (min)* 43.5±12.8 45.3±13.3 .212
Cold ischemia time (h)* 6.9±2.7 6.8±2.9 .781
Graft type
Whole organ 127 (94.8) 237 (92.6) .506
Living 6 (4.5) 13 (5.1)
Split 1 (0.7) 6 (2.3)
TABLE  1 Donor and recipient 
characteristics and surgical variables 
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The probability over time that a patient transplanted for primary 
sclerosing cholangitis had biliary complication using the Log- rank test 
was compared between two mentioned groups.
In the D- D group, 1- year survival was 97%, 3- year 95%, and 5- year 
92%, respectively; the Roux- en- Y group had a 1- year survival of 98%, 
a 3- year 97%, and 5- year 94%, respectively; as it can be seen, there 
were no significant differences (P value=.61) (Figure 2).
From the 405 cases, 35 had graft loss (8.6%), from which 7 (4.9%) 
were in the D- D group and 28 (10.8%) in the R- Y group. The most com-
mon causes of graft failure were PSC recurrence and chronic rejection.
Graft survival and graft loss rates in the two groups were com-
pared via the log- rank test. In the D- D group, 1- year survival was 98%, 
3- year 95%, and 5- year 92%; the R- Y group had a 1- year survival of 
96%, a 3- year 91%, and a 5- year 91%, respectively, which showed no 
significant difference with the D- D group (P value=.067; Figure 3).
Frequency of liver re- transplantations was not statistically sig-
nificant between the two groups; the numbers were three (2.1%) 
and four (1.5%) in groups D- D and Roux- en- Y, respectively (P 
value=.702).
4  | DISCUSSION
Liver transplantation is the only effective treatment available to pa-
tients with PSC. Generally speaking, of the two methods of biliary re-
construction, Roux- en- Y has been the method of choice for patients 
with PSC. This theory of preference is based on using the end section 
of the recipients’ common bile ducts, which could get damaged as a 
result of chronic PSC. Also, D- D anastomosis increases postoperative 
biliary complications, even cholangiocarcinoma.7,8
In this study, records of PSC (405) cases who received liver trans-
plants in the biggest center in Iran were analyzed; 64.5% of the pa-
tients had received Roux- en- Y anastomosis. The average follow- up 
was 30 months and 21 days.
Anastomotic strictures (AS) occurred in 4% of the cases; results 
showed lower numbers compared to the results from a previous study 
in America. This difference could have been due to the differences in 
definition, diagnosis, and follow- up duration.9 Studies have reported 
AS and non-anastomotic stricture (NAS) of 4- 9% and 10%- 25%, 
 respectively.10,11 Incidence rate of AS in our study was comparable 
with other studies.
Previous studies had not found any differences between these two 
groups regarding biliary stricture and leakage as our study.8,9
This correlation between Roux- en- Y choledochejejunostomy and 
biliary strictures, which was observed in other studies as well, could be 
the explanation for its frequent usage; therefore, this method cannot 
be an independent risk factor for strictures.
F IGURE  2 The probability of biliary 
complication in primary sclerosing 
cholangitis patients after liver 
transplantation
TABLE  2 Causes of death after liver transplantation
n %
Sepsis/infection 16 4
Chronic rejection 12 3
Cholangiocarcinoma 10 2.5
Graft loss 6 1.5
Malignancy 5 1.2
MI 4 1
PNF 4 1
Severe bleeding 3 0.7
Post- transplantation lymphoproliferative 
disorder
2 0.5
Vascular 2 0.5
Renal failure 1 0.2
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Previous studies have considered Roux- en- Y choledochejejunos-
tomy as a risk factor for NAS, because this method facilitates bacterial 
ascension through the connection between intrahepatic bile ducts and 
intestines, and consequently cholangitis. Frequent infections can lead 
to occurrence and progression of NAS.12
Among our patients, only one case of cholangitis was observed 
in the Roux- en- Y choledochejejunostomy group. One meta- analysis, 
which made a comparison of the two biliary reconstruction methods, 
reported higher occurrence rate of cholangitis in the Roux- en- Y group 
compared to D- D. But there were no differences between the groups 
regarding strictures in general, AS, and biliary leakage.6
In our study, we saw no biliary leakages in any of the reconstructed 
methods, which was similar to the results of two American studies 
which used these two methods.3,9 However, other studies have re-
ported cases of biliary leakage, but none of those studies had seen any 
differences between the two reconstructed methods.5
Compared to other studies, 5- year survival rate was lower among 
our patients.12-15 But one other study had reported results similar 
to ours (76%)1; this could be as a result of the number of accidental 
 cholangiocarcinoma cases observed during surgery.
In this study, we did not observe any differences between the two 
methods regarding patient and graft survival rates, which was not con-
sistent with results from two meta- analyses.5,6 Goss et al. experience 
showed that PSC patients’ survival had no relations with pre- operative 
factors and biliary reconstruction methods.16
In our study, the most common cause of death was sepsis (4%), a 
result which was consistent with other studies.15
In this retrospective study, we did not have the ability to show the 
equality of these two methods; it is recommended to design a clinical 
trial to compare these two biliary reconstruction methods. Despite 
the fact that the first liver transplantation for patient with PSC was 
preformed 19 years ago, however, most of the cases received trans-
plants in the recent years and need more time for follow- ups.
5  | CONCLUSION
MRCP is a good procedure in assessment of patients with PSC be-
fore transplant. If the extrahepatic bile ducts are normal and intra- 
operative observations confirm it, D- D anastomosis would be an 
acceptable alternative. Furthermore, D- D anastomosis has postop-
erative advantages such as easier access to bile ducts via endoscopy 
and lower risk of cholangitis. This method produces similar result to 
Roux- en- Y choledochojejunostomy with regard to complications and 
rate of survival.
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